MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million

Core Viewpoint - MustGrow Biologics Corp. is initiating a non-brokered private placement to raise up to $2,000,000 through the sale of 4,000,000 units at a price of $0.50 per unit, aimed at supporting its agricultural product initiatives and working capital needs [1][3]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant exercisable for 60 months at an exercise price of $0.70 per share [2]. - The closing of the LIFE Offering is expected around January 22, 2026, subject to necessary approvals, including from the TSX Venture Exchange [6]. Group 2: Use of Proceeds - The net proceeds from the LIFE Offering will be allocated for inventory production of the mustard-derived organic biofertility product TerraSanteTM, inventory for agricultural products via NexusBioAg, and general corporate purposes [3]. Group 3: Regulatory Compliance - The offering will be conducted under the listed issuer financing exemption, allowing it to be offered in Canada and certain other jurisdictions without a prospectus [7]. - Units sold to insiders will be subject to a four-month hold period, and the transaction will be considered a related party transaction under Multilateral Instrument 61-101 [9]. Group 4: Company Overview - MustGrow Biologics Corp. specializes in biological and regenerative agriculture solutions, focusing on eco-friendly alternatives to synthetic chemicals and fertilizers [12]. - The company holds approximately 110 patents and aims to drive shareholder value through the commercialization of its proprietary products and technologies [12].